Semax is a synthetic peptide investigated in research involving neurological and neurochemical pathways. It is not an FDA-approved routine medicine.

The Xeno Labs listing specifies a 5 mg strength but does not establish its dosage form, formulation, salt form, or package size. These specifications should be confirmed from the manufacturer’s current documentation.

FDA has considered Semax-related substances in its compounding review process, including uses investigated for neurological conditions. GORoids should verify current labeling and regulatory status before publication